Analytics and digital tools are far more expansive than they were before the pandemic and are influencing how tenants make ...

Researchers observed significant racial/ethnic disparities in receipt of percutaneous coronary intervention among patients ...

VQ-101 is the first small molecule to demonstrate >70% activation of the lysosomal enzyme glucocerebrosidase (GCase) in GBA-Parkinson’s ...

Suspected stroke and acute cardiac events in-flight were associated with high likelihood of flight diversions, especially if ...

Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of ...

The global nonprofit WITNESS seeks to address one of the biggest data gaps in the digital verification landscape: the ...

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on ...

Cyclerion Therapeutics, Inc. ( NASDAQ: CYCN) Pioneering a New Era in Neuropsychiatric Therapies Conference September 24, 2025 10:30 AM EDT ...

SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...

DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced ...

PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory ...